arrow
D

Dumith Chequer Bou-Habib

(no valid institution found)
H指数:28
被引数:3,233

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mast cells release DNA Extracellular Traps (DETs) in response to SARS-CoV-2 and its spike protein

肥大细胞对SARS-CoV-2及其刺突蛋白产生反应释放细胞外DNA陷阱(DETs)

2026-05-290
OAAI
Neutrophil extracellular traps promote macrophage activation through Toll-like receptor engagement and PKA and NF-kB signaling pathways

中性粒细胞胞外陷阱通过Toll样受体结合以及PKA和NF-κB信号通路促进巨噬细胞活化

2026-05-280
OAAI
Inactivated SARS-CoV-2 induces acute skeletal muscle damage in human K18-hACE2 transgenic mice
2025-03-010
PRE
Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice
2024-11-290
OAAI
Diminazene aceturate inhibits the SARS-CoV-2 spike protein-induced inflammation involving leukocyte migration and DNA extracellular traps formation
2024-09-011
PRE
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
2023-01-139
OAAI
Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
2022-04-2227
OAAI
VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells
2022-03-2422
OA
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
2022-02-1835
OAAI
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
2022-02-1114
OAAI
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes (vol 7, 43, 2021)
2021-05-195
OAAI
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
2021-04-2160
OA
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
2021-03-01199
OAAI
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
2020-12-16212
OAAI